HCPCS Level IIdrugActive
J9317
Sacituzumab govitecan-hziy
BETOS: O1D
Effective: 2021-01-01
Description
Injection, sacituzumab govitecan-hziy, 2.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Trodelvy
Manufacturer
Immunomedics, Inc.
HCPCS Dosage
2.5 MG
Billing Units
72.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.